Pryse-Davies J - Search Results

1

Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.

Hillard TC, Siddle NC, Whitehead MI, Fraser DI, Pryse-Davies J. Hillard TC, et al. Among authors: pryse davies j. Am J Obstet Gynecol. 1992 Jul;167(1):1-7. doi: 10.1016/s0002-9378(11)91614-7. Am J Obstet Gynecol. 1992. PMID: 1442905

2

Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone.

Siddle NC, Fraser D, Whitehead MI, Jesinger DK, Endacott J, Prescott P, Pryse-Davies J. Siddle NC, et al. Among authors: pryse davies j. Br J Obstet Gynaecol. 1990 Dec;97(12):1101-7. doi: 10.1111/j.1471-0528.1990.tb02497.x. Br J Obstet Gynaecol. 1990. PMID: 2177648 Clinical Trial.

3

The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.

Fraser DI, Parsons A, Whitehead MI, Wordsworth J, Stuart G, Pryse-Davies J. Fraser DI, et al. Fertil Steril. 1990 Mar;53(3):460-8. doi: 10.1016/s0015-0282(16)53341-x. Fertil Steril. 1990. PMID: 2407564 Free article. Clinical Trial.

4

The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy.

Fraser DI, Padwick ML, Whitehead MI, White J, Ryder TA, Pryse-Davies J. Fraser DI, et al. Maturitas. 1989 Mar;11(1):21-34. doi: 10.1016/0378-5122(89)90117-5. Maturitas. 1989. PMID: 2725335 Clinical Trial.

5

Are fixed-dose oestrogen/progestogen combinations ideal for all HRT users?

Fraser D, Whitehead MI, Endacott J, Morton J, Ryder TA, Pryse-Davies J. Fraser D, et al. Br J Obstet Gynaecol. 1989 Jul;96(7):776-82. doi: 10.1111/j.1471-0528.1989.tb03315.x. Br J Obstet Gynaecol. 1989. PMID: 2765426

6

Endometrial responses to transdermal estradiol in postmenopausal women.

Whitehead MI, Padwick ML, Endacott J, Pryse-Davies J. Whitehead MI, et al. Am J Obstet Gynecol. 1985 Aug 15;152(8):1079-84. doi: 10.1016/0002-9378(85)90566-6. Am J Obstet Gynecol. 1985. PMID: 4025456

7

Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?

Fraser D, Whitehead M, Schenkel L, Pryse-Davies J. Fraser D, et al. Among authors: pryse davies j. Maturitas. 1993 Jan;16(1):23-30. doi: 10.1016/0378-5122(93)90130-a. Maturitas. 1993. PMID: 8429801

8

Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women.

Ross D, Cooper AJ, Pryse-Davies J, Bergeron C, Collins WP, Whitehead MI. Ross D, et al. Among authors: pryse davies j. Am J Obstet Gynecol. 1997 Oct;177(4):937-41. doi: 10.1016/s0002-9378(97)70297-7. Am J Obstet Gynecol. 1997. PMID: 9369848 Clinical Trial.

9

Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometrium.

Ross D, Godfree V, Cooper A, Pryse-Davies J, Whitehead MI. Ross D, et al. Among authors: pryse davies j. Maturitas. 1997 Sep;28(1):83-8. doi: 10.1016/s0378-5122(97)00058-3. Maturitas. 1997. PMID: 9391999 Clinical Trial.

10

Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?

Lane G, Siddle NC, Ryder TA, Pryse-Davies J, King RJ, Whitehead MI. Lane G, et al. Fertil Steril. 1986 Mar;45(3):345-52. Fertil Steril. 1986. PMID: 3005052 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters